Atlanta trial law firm representing clients nationwide in personal injury, mass torts, and dangerous drug cases. Over $750 million recovered for injured clients.
At Childers, Schlueter & Smith, justice extends beyond the courtroom. Firm Partner Richard Schlueter and his wife, Michelle, turned Richard’s battle with stage-4 cancer into a mission for change—advocating for stronger NIH funding and lifesaving research.
A federal lawsuit alleges the Atlanta Dream Center Church and others ran a labor trafficking scheme disguised as missionary training, forcing victims into years of unpaid labor under inhumane conditions and religious coercion.
A Missouri mother whose NEC infant formula lawsuit was dismissed will get a new trial after a judge ruled the defense misled jurors. The case renews hope for families seeking justice over dangerous cow’s milk-based preterm formulas.
The Judicial Panel on Multidistrict Litigation consolidated 15 federally filed morcellator cases on Thursday for pre-trial discovery and trial work up. The request for the Morcellator MDL was made by Plaintiffs in an effort to streamline the litigation and fast track the efficient handling of the…
A lawsuit filed last week in state court in Philadelphia, Pennsylvania alleges that Xarelto’s recommended dosage doesn’t work for as long as is represented by the manufacturer, Janssen Pharmaceuticals and Bayer HealthCare. It is believed to be the first in the nation to allege that…
According to a study conducted by researchers for Johns Hopkins Bloomberg School of Public Health and George Washington University that was published on April 24, 2015 in the British Medical Journal, Xarelto may present double warfarin’s risk of serious gastrointestinal bleeds, and Pradaxa may incre
The U.S. Food and Drug Administration (FDA) has rejected three attempts by Johnson & Johnson to expand the approval of its anti-blood clotting drug, Xarelto, according to a report in the Wall Street Journal. Xarelto is approved as a preventative medicine for patients with pulmonary…
On Friday, February 20, 2015, DePuy/ Johnson & Johnson agreed to pay approximately $420 million more to resolve approximately 1400 additional DePuy ASR lawsuits. The order came from the Court extending the settlement offer to Plaintiffs who had revision surgery after August 31, 2013 up…
On December 22, 2014, China officially approved imports of a type of genetically modified corn – Syngenta’s Agrisure Viptera® MR162, ending China’s yearlong ban of imports of all corn containing any trace of the Viptera MR162 trait. The ban had essentially shut U.S. corn out…
Just over two years since the Stryker Rejuvenate and ABGII hip implant products were recalled from the market in June 2012, national leadership in the multi-district litigation (MDL) today announced a global settlement proposal for all Stryker Rejuvenate and ABGII hip implant victims who have…
Nearly 3,000 lawsuits have been filed against Stryker related to their Rejuvenate and ABG II Modular-Neck Stem Hip Implants. Here are some common questions that patients and the general public may have regarding these products: 1) Why were the Stryker Rejuvenate and ABG II Modular-Neck…
